BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25685272)

  • 1. Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future.
    Pandya GJ; Shelat VG
    World J Gastrointest Oncol; 2015 Feb; 7(2):6-11. PubMed ID: 25685272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of radio-ablative technique for optimizing the survival of patients with locally advanced pancreatic adenocarcinoma (Review).
    Iancu I; Bartoș A; Cioltean CL; Breazu C; Iancu C; Bartoș D
    Exp Ther Med; 2021 Aug; 22(2):853. PubMed ID: 34178126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
    Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
    Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Endoscopic Ultrasound-Guided Radiofrequency Ablation in Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Center Historic Cohort Study.
    Robles-Medranda C; Del Valle R; Puga-Tejada M; Arevalo-Mora M; Cunto D; Egas-Izquierdo M; Estrada-Guevara L; Bunces-Orellana O; Moreno-Zambrano D; Alcivar-Vasquez J; Alvarado-Escobar H; Merfea RC; Barreto-Perez J; Rodriguez J; Calle-Loffredo D; Pitanga-Lukashok H; Baquerizo-Burgos J; Tabacelia D
    Gastrointest Endosc; 2024 Mar; ():. PubMed ID: 38518978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nine-year survival of a 60-year-old woman with locally advanced pancreatic cancer under repeated open approach radiofrequency ablation: A case report.
    Zhang JY; Ding JM; Zhou Y; Jing X
    World J Clin Cases; 2022 Nov; 10(32):11845-11852. PubMed ID: 36405299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma.
    Thosani N; Cen P; Rowe J; Guha S; Bailey-Lundberg JM; Bhakta D; Patil P; Wray CJ
    Sci Rep; 2022 Oct; 12(1):16516. PubMed ID: 36192558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review.
    Paiella S; Salvia R; Ramera M; Girelli R; Frigerio I; Giardino A; Allegrini V; Bassi C
    Gastroenterol Res Pract; 2016; 2016():4508376. PubMed ID: 26981115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
    Geboers B; Ruarus AH; Nieuwenhuizen S; Puijk RS; Scheffer HJ; de Gruijl TD; Meijerink MR
    Chin Clin Oncol; 2019 Dec; 8(6):61. PubMed ID: 31865711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION FOR PANCREATIC ADENOCARCINOMA.
    Wray CJ; O'Brien B; Cen P; Rowe JH; Faraoni EY; Bailey JM; Rubin E; Tammisetti VS; Thosani N
    Gastrointest Endosc; 2024 May; ():. PubMed ID: 38729313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients.
    Paiella S; Malleo G; Cataldo I; Gasparini C; De Pastena M; De Marchi G; Marchegiani G; Rusev B; Scarpa A; Girelli R; Giardino A; Frigerio I; D'Onofrio M; Secchettin E; Bassi C; Salvia R
    Langenbecks Arch Surg; 2018 Mar; 403(2):213-220. PubMed ID: 28983662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview.
    D'Onofrio M; Barbi E; Girelli R; Martone E; Gallotti A; Salvia R; Martini PT; Bassi C; Pederzoli P; Pozzi Mucelli R
    World J Gastroenterol; 2010 Jul; 16(28):3478-83. PubMed ID: 20653055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study on radiofrequency ablation locally advanced pancreatic cancer.
    Casadei R; Ricci C; Pezzilli R; Serra C; Calculli L; Morselli-Labate AM; Santini D; Minni F
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):306-11. PubMed ID: 20525559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis.
    Dhaliwal A; Kolli S; Dhindsa BS; Choa J; Mashiana HS; Ramai D; Chandan S; Bhogal N; Sayles H; Bhat I; Singh S; Adler DG
    Endosc Int Open; 2020 Oct; 8(10):E1243-E1251. PubMed ID: 33015325
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma.
    D'Onofrio M; Barbi E; Girelli R; Tinazzi Martini P; De Robertis R; Ciaravino V; Salvia R; Butturini G; Frigerio I; Milazzo T; Crosara S; Paiella S; Pederzoli P; Bassi C
    J Gastrointest Oncol; 2016 Apr; 7(2):213-20. PubMed ID: 27034788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy.
    Rossi G; Petrone MC; Schiavo Lena M; Albarello L; Palumbo D; Testoni SGG; Archibugi L; Tacelli M; Zaccari P; Vanella G; Apadula L; Crippa S; Belfiori G; Reni M; Falconi M; Doglioni C; De Cobelli F; Healey AJ; Capurso G; Arcidiacono PG
    DEN Open; 2023 Apr; 3(1):e152. PubMed ID: 35898840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
    Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Radiofrequency Ablation in the Management of Unresectable Pancreatic Cancer.
    Yousaf MN; Ehsan H; Muneeb A; Wahab A; Sana MK; Neupane K; Chaudhary FS
    Front Med (Lausanne); 2020; 7():624997. PubMed ID: 33644089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.
    Enriquez JS; Chu Y; Pudakalakatti S; Hsieh KL; Salmon D; Dutta P; Millward NZ; Lurie E; Millward S; McAllister F; Maitra A; Sen S; Killary A; Zhang J; Jiang X; Bhattacharya PK; Shams S
    JMIR Med Inform; 2021 Jun; 9(6):e26601. PubMed ID: 34137725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study.
    Fegrachi S; Walma MS; de Vries JJJ; van Santvoort HC; Besselink MG; von Asmuth EG; van Leeuwen MS; Borel Rinkes IH; Bruijnen RC; de Hingh IH; Klaase JM; Molenaar IQ; van Hillegersberg R
    Eur J Surg Oncol; 2019 Nov; 45(11):2166-2172. PubMed ID: 31227340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.